{"name":"Suzhou HepaThera Biotech Co., Ltd.","slug":"suzhou-hepathera-biotech-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"HT-102","genericName":"HT-102","slug":"ht-102","indication":"Other","status":"phase_2"},{"name":"HT-101","genericName":"HT-101","slug":"ht-101","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"HT-102","genericName":"HT-102","slug":"ht-102","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"HT-101","genericName":"HT-101","slug":"ht-101","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNYXNVcGVCOUx3b0paRVYyNXYzOC1OUFF3RnJVaVZpUVdEZlN5M2pJYzdLZU5IWHdoSXd1SUltcFRQNjBmUldrTm5QaF9tSTVfemtSbVREVDMzcnZBb3U0TWVqc2oxS2dUZktaYWNzRDUxZ19IR21zRnRVU1VVelJhRFozX1FWV0pmNGItc3ZSQk5BX1VGVHNkRjFwQmlKN3doRmNOVA?oc=5","date":"2025-02-12","type":"pipeline","source":"BioWorld News","summary":"Biomissile’s multispecific antibodies harness NK cell engagers - BioWorld News","headline":"Biomissile’s multispecific antibodies harness NK cell engagers","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}